Caricamento...
Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic
Federal regulatory changes during the COVID-19 pandemic allow buprenorphine to be prescribed without an initial in-person evaluation. Prior to COVID-19, numerous barriers limited broad uptake of buprenorphine among people who use drugs at the system, provider, and patient levels, including lack of a...
Salvato in:
| Pubblicato in: | J Subst Abuse Treat |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier Inc.
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7833481/ https://ncbi.nlm.nih.gov/pubmed/33771276 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsat.2020.108272 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|